The present invention is directed to fluorophosphates, and pharmaceutical compositions thereof, which are inhibitors of intestinal apical sodium/phosphate co-transport and are useful in the treatment of hyperphosphatemia, in reducing blood phosphate levels, and in treating hypertension.La présente invention concerne des fluorophosphates et des compositions pharmaceutiques de ces fluorophosphates, qui sont des inhibiteurs du cotransport sodium/phosphate apical intestinal et qui sont utiles dans le traitement de lhyperphosphatémie, la réduction des niveaux de phosphate sanguin, et le traitement de lhypertension.
